We describe a case of multicentric reticulo-histiocytosis. It is a rare condition but one which causes significant morbidity to skin and joints. There is no consensus on treatment, but here we report a good response to infliximab. We also use the case to emphasise the value of skin biopsy in diagnosing rheumatological conditions.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: